Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme

Acta Neurologica Scandinavica

Volumn 122, Issue 3, 2010, Pages 159-167

  Helseth, R ^a   Helseth, E ^b,c   Johannesen, T B ^d   Langberg, C W ^c   Lote, K ^e   Ronning P ^c   Scheie, D ^e   Vik, A ^a,f   Meling, T R ^e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

glioblastoma; primary treatment; prognostic factors; repeated surgery; survival

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; FEMALE; GLIOBLASTOMA; HUMAN; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; SEIZURE; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955293318     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01350.x     Document Type: Article

References (29)

1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005 109 : 93 108.
2. Kleihues P, Burger PC, Aldape KD et al. Glioblastoma. In : Louis D et al, eds. WHO classification of tumours of the central nervous system. Lyon : IARC Press, 2007 72 3.
3. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005 353 : 811 822.
4. Lim DA, Cha S, Mayo MC et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007 9 : 424 429.
5. Stupp R, Mason WP, Van Den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005 352 : 987 996.
6. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993 71 : 2585 2597.
7. Walker MD, Green SB, Byar DP et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980 303 : 1323 1329.
8. Barker FG Ii, Prados MD, Chang SM et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996 84 : 442 448.
9. Lacroix M, Abi-Said D, Fourney DR et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001 95 : 190 198.
10. Laws ER, Parney IF, Huang W et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003 99 : 467 473.
11. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006 7 : 392 401.
12. Ryken TC, Frankel B, Julien T, Olson JJ. Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol 2008 89 : 271 286.
13. Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009 10 : 459 466.
14. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005 352 : 997 1003.
15. Rogne SG, Konglund A, Meling TR et al. Intracranial tumor surgery in patients >70 years of age: is clinical practice wortwhile or futile? Acta Neurol Scand 2009 120 : 288 294.
16. Chang SM, Parney IF, Mcdermott M et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 2003 98 : 1175 1181.
17. Terasaki M, Ogo E, Fukushima S et al. Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. Surg Neurol 2007 68 : 250 254.
18. Barbagallo GM, Jenkinson MD, Brodbelt AR. 'Recurrent' glioblastoma multiforme, when should we reoperate? Br J Neurosurg 2008 22 : 452 455.
19. Franceschi E, Tosoni A, Bartolini S, Mazzocchi V, Fioravanti A, Brandes AA. Treatment options for recurrent glioblastoma: pitfalls and future trends. Expert Rev Anticancer Ther 2009 9 : 613 619.
20. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 : 649 655.
21. Kristiansen K, Hagen S, Kollevold T et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981 47 : 649 652.
22. Mirimanoff RO, Gorlia T, Mason W et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006 24 : 2563 2569.
23. Barnholtz-Sloan JS, Williams VL, Maldonado JL et al. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 2008 108 : 642 648.
24. Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases Cancer 2005 103 : 1234 1244.
25. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM. Glioblastoma - the consequences of advanced patient age on treatment and survival. Neurosurg Rev 2007 30 : 56 61.
26. Sher DJ, Henson JW, Avutu B et al. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma. J Neurooncol 2008 88 : 43 50.
27. Mandl ES, Dirven CM, Buis DR, Postma TJ, Vandertop WP. Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol 2008 69 : 506 509. discussion 9.
28. Klein M, Heimans JJ, Aaronson NK et al. Effect of radio-therapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002 360 : 1361 1368.
29. Esteller M, Garcia-Foncillas J, Andion E et al. Inactiva-tion of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000 343 : 1350 1354.